Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $7.48 Million - $14.8 Million
598,298 New
598,298 $8.56 Million
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $769,636 - $1.13 Million
-37,361 Reduced 6.35%
551,176 $14.1 Million
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $4.48 Million - $6.44 Million
171,920 Added 41.27%
588,537 $16.7 Million
Q1 2022

May 11, 2022

BUY
$24.46 - $40.92 $155,051 - $259,391
6,339 Added 1.55%
416,617 $14.7 Million
Q4 2021

Feb 11, 2022

BUY
$35.0 - $45.94 $1.73 Million - $2.28 Million
49,562 Added 13.74%
410,278 $17.2 Million
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $3.21 Million - $5.29 Million
87,254 Added 31.91%
360,716 $17.7 Million
Q2 2021

Aug 11, 2021

BUY
$32.46 - $45.0 $3.63 Million - $5.03 Million
111,832 Added 69.19%
273,462 $11.4 Million
Q1 2021

May 13, 2021

BUY
$25.8 - $38.49 $4.17 Million - $6.22 Million
161,630 New
161,630 $5.76 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.